RE:RE:RE:RE:RE:Recorded Message From CEOI will say that had the board asked for a vote on 5:1 or anything higher I would be thinking twice. But a 2:1 with the recent changes to the site, Care Oncology deal, the FAQ on the deal, the recent online interviews and maybe more this week (wink wink). I have no issue supporting the board with the 2:1.
Am I happy with how things have worked out on Aristotle so far. Of course not. Do I see very positive changes and the company working on execution to roll this out. Yes I do.
A 2:1 r/s over the next 12 months has way more reward than risk. They don't need it for financing as they have enough free shares if they wanted a PP. Doing it now to get a $1 share price won't change anything so I have to believe it will be used for something else when needed.
Voting against it is just bashers trying to continue the short attack or uninformed shareholders who are just upset and not seeing the future here. Shooting themselves in the foot because they allowed bashers to get in their heads.
If you don't think stage can turn this around than sell and move on. Why would you stay?
If you think they are back on the right track than vote for the 2:1 and let them execute
Mykndrsn wrote: Another genius with more knowledge, insight and experience than the CEO and board of directors. Please share your qualifications.